Shukun Technology Unveils Groundbreaking AI Solution for Coronary Artery Disease Imaging at ASCI 2018, Demonstrating High Diagnostic Accuracy and 30-Second Structured Reporting

VCBeat (WeChat ID: vcbeat) has learned that the 12th Annual Meeting of the Asian Society of Cardiovascular Imaging (ASCI) concluded successfully on August 18, marking the second time ASCI has held its annual academic conference in Beijing.

Themed “Cardiovascular Imaging and the Belt and Road Initiative,” this conference brought together the most renowned cardiovascular imaging experts from across Asia, representing the highest academic standards and developmental directions in the field within the region. It also featured participation from numerous colleagues and experts from organizations such as the European Association of Cardiovascular Imaging (EACVI), the European Society of Cardiovascular Radiology (ESCR), the Society for Cardiovascular Magnetic Resonance (SCMR), and the North American Society for Cardiovascular Imaging (NASCI).

In addition to offering the latest developments, such as authoritative expert lectures, knowledge updates, and research advancements, for a broad audience of physicians, the conference also provides a diverse array of content for young scholars, including training courses, researcher presentations, young scholar forums, and poster sessions (including e-posters).

It is also worth noting that the conference has established a special focus section, highlighting the latest applications of “Artificial Intelligence” in the field of cardiovascular disease. This is also one of the buzzwords specifically mentioned by the Conference Chair in the meeting invitation.

Professor Lü Bin from Fuwai Hospital, Chinese Academy of Medical Sciences, the Executive Chair of the Annual Conference, conducted on-site questioning.

As a leading AI-driven healthcare technology company, Shukun Technology was invited to participate in this prestigious event. On August 18, during the special session titled “Spotlight on Artificial Intelligence,” CEO Ma Chun’e delivered a keynote address entitled “Exploration and Practice of Artificial Intelligence in the Diagnosis of Coronary Heart Disease.”

According to Ma Chun’e, China has a large population of patients with cardiovascular disease, and cardiovascular disease ranks as the leading cause of death among both urban and rural residents. The survival rate for cardiovascular disease, when promptly prevented and treated through imaging-based diagnosis, is significantly higher than that for cancer.

Computed Tomography Angiography (CTA), as a pivotal method for the clinical diagnosis of coronary heart disease, is being widely adopted worldwide. However, the accuracy of CTA image analysis still faces numerous challenges, and current CTA imaging solutions require extensive manual interaction, compelling radiologists to devote significant time to image processing. This underscores the need for specialized intelligent tools designed for the accurate reconstruction of CTA images, thereby assisting radiologists and cardiologists in disease diagnosis and assessment.

Leveraging its robust scientific research capabilities, Shukun Technology has launched the world’s first AI-powered diagnostic product for cardiovascular diseases. The product automatically generates intelligent structured reports in just 30 seconds.

Unlike previous imaging AI technologies, this product employs more sophisticated algorithmic models and higher-quality data support, enabling complex scenario-based decision-making for multiple targets. Currently, the product has been deployed in clinical practice at hospitals across China, including Beijing Friendship Hospital of Capital Medical University, The First Affiliated Hospital of Zhengzhou University, Wuhan Central Hospital, and Hanzhong Central Hospital.

In the future, Shukun Technology will also develop a series of new products aimed at providing accurate and rapid image analysis solutions to assist in the diagnosis and monitoring of coronary heart disease and cerebrovascular diseases.

To the delight of radiologists, Shukun AI’s diagnostic product, CoronaryDoc, could be integrated into the standard workflow by the afternoon following its morning installation, eliminating the need for a prolonged commissioning period.

Moreover, Shukun Technology has assigned dedicated technical personnel to be stationed at the hospital to monitor equipment usage in real time, solicit feedback and suggestions from physicians, assist radiologists new to the system in rapidly mastering post-processing and report generation, and provide technical solutions for cases with suboptimal image quality.

As a vital force in the radiology department, middle-aged physicians are amazed by the speed of report generation. The reports issued by CoronaryDoc fully comply with the CT Angiography Reporting and Data System (CAD-RADS) jointly published by the Society of Cardiovascular Computed Tomography (SCCT), the American College of Radiology (ACR), and the North American Society for Cardiovascular Imaging (NASCI). From image input to report output, the process takes only one minute, and the volume of report verification and revisions has been reduced to one-fifth of the original level. “We no longer have to worry about being buried in report writing or correcting the error-ridden reports drafted by junior doctors!”

According to VCBeat, CoronaryDoc has been piloted in multiple hospitals across China, serving as an intelligent workflow assistant for radiologists. As AI products continue to mature, it is expected that more such solutions will be presented at prestigious academic platforms and gradually implemented in hospitals at all levels, thereby freeing physicians from cumbersome routine tasks.

As envisioned by Ma Chun’e, CEO of Shukun Technology, the era of medical AI is dawning.